Epidural steroid injections may modestly reduce pain and disability for certain chronic back pain conditions, but their ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...

There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

A new study by the American Academy of Neurology finds limited evidence supporting epidural steroid injections for chronic ...

Researchers found that epidural steroid injections may modestly reduce pain and disability in patients with a pinched nerve ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Vertex is studying suzetrigine in sciatica; in a phase II trial, the drug showed a statistically significant change in lumbosacral radiculopathy pain from baseline, similar to the reduction in the ...

For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce ...